Open Access

Cholinesterase inhibitors as Alzheimer's therapeutics (Review)

  • Authors:
    • Kamlesh Sharma
  • View Affiliations

  • Published online on: June 11, 2019     https://doi.org/10.3892/mmr.2019.10374
  • Pages: 1479-1487
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Alzheimer's disease (AD) is one of the most common forms of dementia. AD is a chronic syndrome of the central nervous system that causes a decline in cognitive function and language ability. Cholinergic deficiency is associated with AD, and various cholinesterase inhibitors have been developed for the treatment of AD, including naturally‑derived inhibitors, synthetic analogues and hybrids. Currently, the available drugs for AD are predominantly cholinesterase inhibitors. However, the efficacy of these drugs is limited as they may cause adverse side effects and are not able to completely arrest the progression of the disease. Since AD is multifactorial disease, dual and multi‑target inhibitors have been developed. The clinical applications and the limitations of the inhibitors used to treat AD are discussed in the present review. Additionally, this review presents the current status and future directions for the development of novel drugs with reduced toxicity and preserved pharmacological activity.
View Figures
View References

Related Articles

Journal Cover

August-2019
Volume 20 Issue 2

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Sharma K: Cholinesterase inhibitors as Alzheimer's therapeutics (Review) . Mol Med Rep 20: 1479-1487, 2019.
APA
Sharma, K. (2019). Cholinesterase inhibitors as Alzheimer's therapeutics (Review) . Molecular Medicine Reports, 20, 1479-1487. https://doi.org/10.3892/mmr.2019.10374
MLA
Sharma, K."Cholinesterase inhibitors as Alzheimer's therapeutics (Review) ". Molecular Medicine Reports 20.2 (2019): 1479-1487.
Chicago
Sharma, K."Cholinesterase inhibitors as Alzheimer's therapeutics (Review) ". Molecular Medicine Reports 20, no. 2 (2019): 1479-1487. https://doi.org/10.3892/mmr.2019.10374